Naropin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 16 USDMF, 11 CEP/COS, 1 JDMF, 12 EU WC, 5 KDMF, 12 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

12 Intermediates Suppliers

12 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

162 FDF Dossiers, 75 FDA Orange Book, 48 Europe, 6 Canada, 11 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INJECTION - 100MG/10ML (10MG/ML), SOLUTION;INJECTION - 100MG/20ML (5MG/ML), SOLUTION;INJECTION - 150MG/30ML (5MG/ML), SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML), SOLUTION;INJECTION - 1GM/200ML (5MG/ML), SOLUTION;INJECTION - 200MG/20ML (10MG/ML), SOLUTION;INJECTION - 200MG/100ML (2MG/ML), SOLUTION;INJECTION - 20MG/10ML (2MG/ML), SOLUTION;INJECTION - 400MG/200ML (2MG/ML), SOLUTION;INJECTION - 40MG/20ML (2MG/ML), SOLUTION;INJECTION - 500MG/100ML (5MG/ML), SOLUTION;INJECTION - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**